Trial
NCT04261712
A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Advance)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Crinetics Pharmaceuticals Inc.
Collaborators
—
Condition
Acromegaly
Intervention
Paltusotine
Why stopped
The study was stopped early for business reasons (not due to changes in the benefits or risks of paltusotine).
Provenance
Dataset: 2026-07-31 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-29